Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Clinical trial NCT01528111 · COMPLETED
Trial details
- NCT number
- NCT01528111
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-06-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.